BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells
- PMID: 1696446
BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells
Abstract
Anti-BLA.36 is an antibody that recognizes a glycoprotein with an apparent molecular weight of 36 kilodaltons, termed B lymphocyte antigen (BLA.36). By using an immunochemical staining technique, BLA.36 was found to be specifically expressed on Hodgkin's and human B cell lines including early B progenitor cells. Other cell lines representing T cell lymphomas, non-B large cell lymphomas, melanomas and carcinomas were consistently negative. BLA.36 is distinct from the previously identified antigens of hematopoietic cell lineage. The specificity of expression of BLA.36 in tissue sections mirrored that of cell lines. In normal tissues, BLA.36 was detectable predominantly on cells in the germinal center and mantle zone of reactive follicles in lymph nodes and spleens. In hematopoietic malignancy, the antigen was expressed on the surface of Reed-Sternberg cells, mononuclear Hodgkin's cells and also on malignant cells of B cell lineage. BLA.36 was also observed on lymphoid cells of 10 to 24 week fetal liver: a double-antibody-staining method revealed that these BLA.36-positive cells also contained immunoglobulin mu heavy chain consistent with identification as early B cells. Under these conditions, T lymphocytes, histiocytes, granulocytes, macrophages, stromal cells in lymphoid tissue, and both normal and neoplastic epithelial cells were consistently negative for the expression of the antigen, with the single exception of a variable proportion of Kupffer cells in normal liver. The antibody has already established its usefulness for the identification of Reed-Sternberg and Hodgkin's cells, and also normal and malignant B lymphocytes in frozen as well as formalin-fixed tissue sections. Furthermore, binding of F(ab)2 fragments of anti-BLA.36 to antigen-positive cell lines specifically inhibited the proliferation of cells. Such an effect was eliminated by the removal of the antibody from the culture-medium, suggesting a possible growth-related function of the antigen in Hodgkin's and B cells.
Similar articles
-
Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.Cancer Res. 1990 Mar 1;50(5):1650-7. Cancer Res. 1990. PMID: 1689214
-
Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.J Immunol. 1985 Jun;134(6):4231-6. J Immunol. 1985. PMID: 3157756
-
Evidence for the release of autocrine growth factor(s) by Hodgkin's cell lines.Anticancer Res. 1996 Jul-Aug;16(4A):1727-32. Anticancer Res. 1996. PMID: 8712691
-
Cultural, morphological, cell membrane, enzymatic, and neoplastic properties of cell lines derived from a Hodgkin's disease lymph node.Cancer Res. 1978 Sep;38(9):3033-43. Cancer Res. 1978. PMID: 209894 Review.
-
Normal and malignant B-cell development with special reference to Hodgkin's disease.Ann Oncol. 1997;8 Suppl 2:79-81. Ann Oncol. 1997. PMID: 9209647 Review.
Cited by
-
Hodgkin's-like lymphoma in a ferret (Mustela putorius furo).J Vet Med Sci. 2017 Oct 7;79(10):1660-1663. doi: 10.1292/jvms.17-0317. Epub 2017 Aug 11. J Vet Med Sci. 2017. PMID: 28804091 Free PMC article.
-
Amputation for histiocytic sarcoma in a cat.J Feline Med Surg. 2012 Feb;14(2):147-50. doi: 10.1177/1098612X11429226. J Feline Med Surg. 2012. PMID: 22314091 Free PMC article.
-
Canine acute leukaemia: 50 cases (1989-2014).Vet Comp Oncol. 2017 Sep;15(3):1101-1114. doi: 10.1111/vco.12251. Epub 2016 Jul 12. Vet Comp Oncol. 2017. PMID: 27402031 Free PMC article.
-
Characterization of respiratory dendritic cells from equine lung tissues.BMC Vet Res. 2017 Nov 6;13(1):313. doi: 10.1186/s12917-017-1240-z. BMC Vet Res. 2017. PMID: 29110660 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials